CardioVascular and Interventional Radiology

, Volume 40, Issue 8, pp 1169–1175 | Cite as

Evaluation of Changes in Sexual Function Related to Uterine Fibroid Embolization (UFE): Results of the EFUZEN Study

  • Hélène Vernhet Kovacsik
  • Denis Herbreteau
  • Sébastien Bommart
  • Jean-Paul Beregi
  • Jean-Michel Bartoli
  • Marc Sapoval
  • The French Society of Interventional and cardiovascular Imaging (SFICV) research group
Clinical Investigation

Abstract

Objectives

The main goal of the study was to evaluate sexual function before and one year after UFE. The secondary goals were to evaluate the quality of life before and one year after UFE and to determine the relation of imaging findings (MRI data) before and 3–6 months after UFE to changes in sexual function and quality of life.

Materials and Methods

Study design: a prospective, multicenter (25 centers) observational study was conducted. Patients: a total of 264 consecutive symptomatic women undergoing UFE using Embozene® (Celonova) from March 2012 to May 2013 were enrolled. Clinical data: the sexual function score and the quality of life score were calculated using the previously validated Female Sexual Function Index (FSFI) by Rosen and UFS-QOL by Spies, respectively, before and one year after UFE. Imaging data: MRI were performed before and 3–6 months after UFE. Data recorded were uterine and main fibroid volume, percentage of fibroid enhancement after injection of gadolinium. Impact of imaging data before and after UFE FSFS scores and QOL scores after UFE was searched.

Results

Complete FSFI study and QOL study were obtained in 170 and 192 women, respectively. At 1 year post-UFE, improvement of FSFI score was seen in 134/170 women (78.8%), QOL scores were improved in 183/203 women (90.2%) and symptoms severity in 163/192 (84.9%). The relation between main fibroid reduction, decrease of fibroid enhancement and global UFS-QOL and FSFI scores was not established.

Conclusion

At one year post-embolization, UFE significantly improves all aspects of sexual function and quality of life.

Keywords

Uterine fibroid embolization Quality of life Uterine arteries 

Notes

Centers Included in SFICV Study

H Vernhet-Kovacsik, CHU Arnaud de Villeneuve, Montpellier; J M Bartoli, AP-HM Hôpital Timone, CHU Marseille; J P Beregi, CHU Carémeau, Nîmes; F Boudghene, CH Gaston Ramon, Sens; P Chabrot, CHU Gabriel Montpied, Clermont-Ferrand; J C Brichaux, Clinique St Etienne, Bayonne; P Chevallier, Hôpital Archet II, CHU Nice; F Cotton, HCL, CHU Lyon Sud; M C Delchier, Hôpital Rangueil, CHU Toulouse; D Herbreteau, CHU Bretonneau, Tours; D Higue, CH Côte Basque, Bayonne; X Kos, Clinique Aressy, Bizanos; D Krause, Hôpital Bocage, CHU Dijon; J C Lasalarie, CHU Sud Réunion; M Lebbadi, CHU Fort de France; J Massonnat, Clinique Axium, Aix-en-Provence; C Poey, Clinique St Paul, Fort de France; P Romy, Clinique Pasteur, Guilherand Granges; G Roumieux, CH Henri Duffaut, Avignon; M Sapoval, AP-HP HEGP, CHU Paris; C Sengel, Hôpital Michallon, CHU Grenoble; F Thouveny, Hôpital Larrey, CHU Angers; H Trillaud, Hôpital St André, CHU Bordeaux; E Uzan, CHP Beauregard, Marseille; O Vignaux, AP-HP Hôpital Cochin, CHU Paris.

Compliance with Ethical Standards

Conflict of interest

None.

References

  1. 1.
    Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005;48(2):312–24.CrossRefPubMedGoogle Scholar
  2. 2.
    Edozien LC. Hysterectomy for benign conditions. BMJ. 2005;330(7506):1457–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Verkauf BS. Myomectomy for fertility enhancement and preservation. Fertil Steril. 1992;58(1):1–15.CrossRefPubMedGoogle Scholar
  4. 4.
    Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, Merland J. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–2.CrossRefPubMedGoogle Scholar
  5. 5.
    Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356(4):360–70.CrossRefPubMedGoogle Scholar
  6. 6.
    Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290–300.PubMedGoogle Scholar
  7. 7.
    Hehenkamp WJ, Volkers NA, Birnie E, Reekers JA, Ankum WM. Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy—results from the randomized clinical embolisation versus hysterectomy (EMMY) Trial. Radiology. 2008;246(3):823–32.CrossRefPubMedGoogle Scholar
  8. 8.
    Voogt M, De Vries J, Fonteijn W, Lohl P, Boekkooi P. Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids. Fertil Steril. 2009;92(2):756–61.CrossRefPubMedGoogle Scholar
  9. 9.
    Mara M, Fucikova Z, Maskova J, Kuzel D, Haakova L. Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2006;126(2):226–33.CrossRefPubMedGoogle Scholar
  10. 10.
    Scheurig C, Gauruder-Burmester A, Kluner C, Kurzeja R, Lembcke A, Zimmermann E, et al. Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Hum Reprod. 2006;21(12):3270–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.CrossRefPubMedGoogle Scholar
  12. 12.
    Hehenkamp WJ, Volkers NA, Bartholomeus W, de Blok S, Birnie E, Reekers JA, Ankum WM. Sexuality and body image after uterine artery embolization and hysterectomy in the treatment of uterine fibroids: a randomized comparison. Cardiovasc Interv Radiol. 2007;30(5):866–75.CrossRefGoogle Scholar
  13. 13.
    Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril. 2003;80(6):1488–94.CrossRefPubMedGoogle Scholar
  14. 14.
    Okolo SO, Gentry CC, Perrett CW, Maclean AB. Familial prevalence of uterine fibroids is associated with distinct clinical and molecular features. Hum Reprod. 2005;20(8):2321–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Lonnée-Hoffmann R, Pinas I. Effects of hysterectomy on sexual function. Curr Sex Health Rep. 2014;6(4):244–51.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Danesh M, Hamzehgardeshi Z, Moosazadeh M, Shabani-Asrami F. The effect of hysterectomy on women’s sexual function: a narrative review. Med Arch. 2015;69(6):387–92.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Yeagley TJ, Goldberg J, Klein TA, Bonn J. Labial necrosis after uterine artery embolization for leiomyomata. Obstet Gynecol. 2002;100(5 Pt 1):881–2.PubMedGoogle Scholar
  18. 18.
    El-Shalakany AH, Nasr El-Din MH, Wafa GA, Azzam ME, El-Dorry A. Massive vault necrosis with bladder fistula after uterine artery embolisation. BJOG. 2003;110(2):215–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Lai AC, Goodwin SC, Bonilla SM, Lai AP, Yegul T, Vott S, DeLeon M. Sexual dysfunction after uterine artery embolization. J Vasc Interv Radiol. 2000;11(6):755–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Arleo EK, Masheb RM, Pollak J, McCarthy S, Tal MG. Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter? Int J Fertil Womens Med. 2007;52(2–3):111–20.PubMedGoogle Scholar
  21. 21.
    Kovacsik HV, Herbreteau D, Sapoval M, Beregi JP, Bommart S, Bartoli JM. Evaluation of change in sexual function related to uterine fibroid embolization (UFE): final results of the french SFICV EFUZEN study. JVIR. 2016;supp3(27):518.Google Scholar

Copyright information

© Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017

Authors and Affiliations

  • Hélène Vernhet Kovacsik
    • 1
  • Denis Herbreteau
    • 2
  • Sébastien Bommart
    • 1
  • Jean-Paul Beregi
    • 3
  • Jean-Michel Bartoli
    • 4
  • Marc Sapoval
    • 5
  • The French Society of Interventional and cardiovascular Imaging (SFICV) research group
    • 6
  1. 1.Department of Interventional and Cardiovascular Imaging, Hospital Arnaud de VilleneuveCHU MontpellierMontpellierFrance
  2. 2.CHU ToursToursFrance
  3. 3.CHU NîmesNîmesFrance
  4. 4.APHM MarseilleMarseilleFrance
  5. 5.APHP ParisParisFrance
  6. 6.C.H.U. Rangueil (Service de Radiologie)Toulouse Cedex 4France

Personalised recommendations